We have worked with Bharat Biotech through a collaborative project on vaccine development. In this project, we studied the immune response in small animals to the inactivated coronavirus.
We have been working with VINS Bioproducts and University of Hyderabad to generate anti-SARS CoV-2 F(ab’)2 specific antibody fragments as a therapeutic intervention in severe COVID-19 patients. The product has shown tremendous neutralization potential in vitro in cell-culture models. The product has cleared toxicology studies and is currently undergoing clinical trials.
If you would like to access inactivated coronavirus or test your vaccine efficacy, please write to email@example.com.